National Cannabis Industry Association Releases Congressional Scorecard Ahead of Midterm Elections
FOR IMMEDIATE RELEASE
Tuesday, October 9, 2018
CONTACT:
Morgan Fox, National Cannabis Industry Association
216-334-9564, Media@TheCannabisIndustry.org
National Cannabis Industry Association Releases Congressional Scorecard Ahead of Midterm Elections
Report judges members of Congress by position on marijuana-related appropriations amendments voted on in House since 2014 and current sponsorship of marijuana legislation
WASHINGTON, D.C. – With midterm elections less than a month away, the National Cannabis Industry Association (NCIA) released a Congressional Scorecard today to inform voters across the country on how their elected representatives have voted on marijuana issues. The scorecard provides the voting history of members of the House of Representatives on marijuana-related appropriations amendments that were considered between 2014 and 2016 as well as identifying cosponsors of the legal cannabis industry’s priority legislation in both the House and Senate
The six specific pieces of legislation that were considered in the scoring were to prevent expenditure of federal funds to interfere with state laws related to hemp production, medical marijuana, adult use cannabis programs, and cannabidiol (CBD); provide safe harbor to financial institutions to work with the legal cannabis industry; and allow doctors in the Veterans Affairs system to discuss cannabis with their patients and recommend it under applicable state laws.
The full scorecard is available at https://www.thecannabisindustry.org/2018scorecard.
“As more and more states move toward ending cannabis prohibition, it is becoming increasingly important for voters to know if their federal representatives are working to protect and promote their states’ successful medical and adult-use marijuana programs,” said Aaron Smith, executive director of the National Cannabis Industry Association. “We hope they will take a hard look at this scorecard, back the lawmakers who support common-sense cannabis policy reform, and hold those who are undermining their constituents accountable.”
The Congressional Scorecard follows the release of NCIA’s latest report, “The New Politics of Marijuana: A Winning Opportunity for Either Party,” which highlights the unprecedented voter support for marijuana policy reform and the legal cannabis industry, and how it will impact current and future elections nationwide.
###
The National Cannabis Industry Association (NCIA) is the largest cannabis trade association in the U.S. and the only organization broadly representing cannabis-related businesses at the national level. NCIA promotes the growth of a responsible and legitimate cannabis industry and works toward a favorable social, economic, and legal environment for that industry in the United States.
Marijuana Research Bill Approved in House Judiciary Committee
FOR IMMEDIATE RELEASE
Thursday, September 13, 2018
CONTACT:
Michael Correia, National Cannabis Industry Association
202-599-9742, Media@TheCannabisIndustry.org
Marijuana Research Bill Approved in House Judiciary Committee
Markup of the Republican-backed bill represents first time the committee has considered marijuana policy reform legislation
WASHINGTON, D.C. – On Thursday, the House Judiciary Committee approved legislation designed to facilitate increased federally-approved research into the potential medical benefits of marijuana. The Medical Cannabis Research Act of 2018 (H.R. 5634), which was originally introduced by Rep. Matt Gaetz (R-FL) and currently has 40 cosponsors, passed in a voice vote.
The bill would increase the number of federally-approved research cannabis manufacturers from one to three. It would also create a pathway for state-approved private cannabis cultivators to provide material to researchers, and requires the Attorney General to annually assess whether the approved supply is adequate to meet research requests. In addition, the legislation clarifies that medical professionals in the Dept. of Veterans Affairs are able to inform their patients about cannabis trials, receive information about ongoing research, and may take part in such research.
This vote represents the first time that the House Judiciary Committee has been willing to consider marijuana policy reform legislation.
“The experiences of the states with medical cannabis laws and the millions of patients helped by those programs have proven that cannabis is an effective medicine, but federal research has always lagged behind. This markup represents a big step toward increasing our base of knowledge about cannabis, but more importantly, it shows that Congress is willing to look at the issue fairly and scientifically,” said Aaron Smith, executive director of the National Cannabis Industry Association. “We commend Rep. Gaetz for introducing this bill and for working so hard to make sure it was seriously considered by the Judiciary Committee.”
Despite the overall benefits provided by the bill, advocates are concerned about several compromise provisions that were added to the original language. A ban on people with marijuana convictions being involved in studies would prevent many of the most skilled and knowledgeable individuals from adding their expertise to research efforts and would disproportionately impact people of color. Legitimate study would be further impeded by requiring production facilities to be pre-approved by law enforcement, who have traditionally opposed efforts to increase research into cannabis.
“The restrictions contained in the Medical Cannabis Research Act are well-meaning but totally unnecessary and do nothing to improve public safety or research efficacy,” Smith continued. “We are hopeful that reasonable debate and Rep. Gaetz’s leadership on this issue will convince lawmakers to remove them before passing this bill.”
###
The National Cannabis Industry Association (NCIA) is the largest cannabis trade association in the U.S. and the only organization broadly representing cannabis-related businesses at the national level. NCIA promotes the growth of a responsible and legitimate cannabis industry and works toward a favorable social, economic, and legal environment for that industry in the United States.
Senate Democratic Leader Introduces Bill to End Federal Marijuana Prohibition
New legislation would remove cannabis from Controlled Substances Act, joins other bills calling for states to choose own policies
WASHINGTON, D.C. – On Wednesday, Senate Minority Leader Chuck Schumer introduced a bill which would remove marijuana from the schedule of controlled substances, allowing states to determine their own cannabis policies without fear of federal interference. Sen. Schumer (D-NY) announced his intention to file the bill in late April following statements by the Trump administration signaling that it would support legislation that would leave cannabis policy to the states.
The Marijuana Freedom and Opportunity Act, cosponsored by Senators Bernie Sanders (I-VT), Tim Kaine (D-VA), and Tammy Duckworth (D-IL), would specifically remove marijuana from the Controlled Substances Act, decriminalizing the substance at the federal level and allowing states to determine their own cannabis policies without the threat of interference. The bill also provides funding to cannabis businesses owned by women and people of color through the Small Business Administration; funds studies on traffic safety, impairment detection technology, and health effects of cannabis; restricts advertising that could appeal to children; and sets aside $100 million over five years to help states develop streamlined procedures for expunging or sealing prior cannabis convictions.
“We commend Senator Schumer for joining the growing chorus of Congressional leaders stepping forward with alternatives to the failed prohibition of marijuana,” said Aaron Smith, executive director of the National Cannabis Industry Association (NCIA). “With millions of Americans already living in states that successfully regulate adult-use cannabis and support for national legalization at record levels, this legislation would finally align federal marijuana policies with mainstream voter sentiment.”
This is the second comprehensive cannabis policy reform bill introduced this month. On June 7, Senators Cory Gardner (R-CO) and Elizabeth Warren (D-MA) introduced the STATES Act, which creates exemptions in the Controlled Substances Act for states that have made cannabis legal for medical or adult use. There are several other pieces of cannabis-related legislation also being considered in Congress.
The introduction of the Marijuana Freedom and Opportunity Act also comes a day after voters in Oklahoma approved a medical cannabis ballot initiative, making it the 30th state with an effective medical cannabis law.
A Quinnipiac University poll released in April found 63% of Americans support legalizing marijuana and 70% oppose federal interference with state-authorized cannabis programs. Cannabis is legal for adults in nine states and the District of Columbia, and there are currently 46 states that allow cannabis in some form.
Oklahoma Voters Approve Medical Cannabis Initiative
State to become 30th in nation with an effective medical cannabis law
OKLAHOMA CITY, Okla. – On Tuesday, voters in Oklahoma approved a measure that will make medical cannabis legal in the state with over 56% popular support. The referendum, known as SQ 788, would allow patients to use medical cannabis to treat their conditions with a recommendation from their doctor. The initiative calls on the state to establish rules governing the licensing and regulation of facilities to cultivate, process, and dispense medical cannabis, and allows patients to cultivate limited amounts of medical cannabis at home.
“In spite of a well-financed and misleading opposition campaign, Oklahoma voters proved that medical cannabis is no longer a controversial issue by enacting a sensible law at the ballot box tonight,” said Aaron Smith, executive director of the National Cannabis Industry Association (NCIA). “We applaud Oklahoma for joining the growing list of states that allow patients to legally access the medicine that works for them.”
The passage of SQ 788 marks the first time that a state medical cannabis ballot initiative has been approved by voters in an electoral primary. Observers were skeptical of the initiative passing in an unprecedented election cycle, particularly given strong and well-funded efforts from opponents to the referendum in the months before the vote.
“The passage of this law is not only a great victory for some of the Sooner State’s most vulnerable citizens – it will also create new business opportunities as the state’s underground market for medical cannabis is replaced by licensed businesses with the potential to create thousands of jobs and millions in new tax revenue,” continued Smith. “We are confident that the standards of professionalism and quality care that have become synonymous with the legal medical cannabis industry will be repeated here for the benefit of seriously ill residents throughout the state.”
With the addition of Oklahoma, there are now effective medical cannabis laws in 30 states, as well as the District of Columbia, Guam, and Puerto Rico. A total of 46 states allow for the medical use of cannabis in some form.
Follow NCIA
Newsletter
Facebook
Twitter
LinkedIn
Instagram
News & Resource Topics
–
This Just In
Member Blog: What Consumers Really Want in a Pre-Roll
Member Blog: The Evolving Cannabis Legal & Regulatory Landscape in 2026